Study of the Effect of Aerosolized, Recombinant Alpha 1-Antitrypsin on Epithelial Lining Fluid Analytes in Subjects With Alpha 1-Antitrypsin Deficiency
This study has been completed.
Baxalta now part of Shire
First Posted: September 12, 2005
Last Update Posted: October 23, 2017
Arriva Pharmaceuticals, Inc.
Information provided by:
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study has been completed.|
|Estimated Study Completion Date:||October 2004|
|Primary Completion Date:||No date given|